Loading…

Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism

The discovery and implementation of thiopurine methyltransferase (TPMT) pharmacogenetics has been a success story and has reduced the suffering from serious adverse reactions during thiopurine treatment of childhood leukaemia and inflammatory bowel disease. This MiniReview summarizes four studies in...

Full description

Saved in:
Bibliographic Details
Published in:Basic & clinical pharmacology & toxicology 2021-01, Vol.128 (1), p.52-65
Main Authors: Zimdahl Kahlin, Anna, Helander, Sara, Wennerstrand, Patricia, Vikingsson, Svante, Mårtensson, Lars‐Göran, Appell, Malin Lindqvist
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33
cites cdi_FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33
container_end_page 65
container_issue 1
container_start_page 52
container_title Basic & clinical pharmacology & toxicology
container_volume 128
creator Zimdahl Kahlin, Anna
Helander, Sara
Wennerstrand, Patricia
Vikingsson, Svante
Mårtensson, Lars‐Göran
Appell, Malin Lindqvist
description The discovery and implementation of thiopurine methyltransferase (TPMT) pharmacogenetics has been a success story and has reduced the suffering from serious adverse reactions during thiopurine treatment of childhood leukaemia and inflammatory bowel disease. This MiniReview summarizes four studies included in Dr Zimdahl Kahlin's doctoral thesis as well as the current knowledge on this field of research. The genotype‐phenotype concordance of TPMT in a cohort of 12 663 individuals with clinically analysed TPMT status is described. Notwithstanding the high concordance, the benefits of combined genotyping and phenotyping for TPMT status determination are discussed. The results from the large cohort also demonstrate that the factors of gender and age affect TPMT enzyme activity. In addition, characterization of four previously undescribed TPMT alleles (TPMT*41, TPMT*42, TPMT*43 and TPMT*44) shows that a defective TPMT enzyme could be caused by several different mechanisms. Moreover, the folate analogue methotrexate (MTX), used in combination with thiopurines during maintenance therapy of childhood leukaemia, affects the metabolism of thiopurines and interacts with TPMT, not only by binding and inhibiting the enzyme activity but also by regulation of its gene expression.
doi_str_mv 10.1111/bcpt.13483
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_DiVA_org_liu_170185</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2471058500</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33</originalsourceid><addsrcrecordid>eNp9ks1u1DAQxyMEoqVw4QFQJC4IKcUf8ca5IJXlU6pED4WrZTvjjavEDrZD2RsPwIFn5Elw2GVFe2AuHsm_-Wk0-hfFY4xOca4XSk_pFNOa0zvFMW5qUjW8pncPPWVHxYMYrxAiTY3R_eKIEr5inLfHxY-LXoZRar8BB8nqMqa5sxBLb8rUWz_NwTooR0j9dkhBumggyAhl5n3aTvDr-8-p3_el9k770EmnoZSuK8EY0GlxLQKfAnyTCUrvbrml8oON48PinpFDhEf796T49PbN5fp9df7x3Yf12Xmla76iley0MoagWhNVM6U62jCQrdJcAVMNNyvgBBGGFGpxxwlhmVBGGaaAY0npSVHtvPEaplmJKdhRhq3w0orX9vOZ8GEjBjsL3CDMWeZf7vgMj9BpcPkSw42xmz_O9mLjv4qGE4xZkwXP9oLgv8wQkxht1DAM0oGfoyA15W2L2npBn95Cr_wcXD5HphqMGGcIZer5jtLBxxjAHJbBSCyhEEsoxJ9QZPjJv-sf0L8pyADeAdd2gO1_VOLV-uJyJ_0NymHJlA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471058500</pqid></control><display><type>article</type><title>Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Zimdahl Kahlin, Anna ; Helander, Sara ; Wennerstrand, Patricia ; Vikingsson, Svante ; Mårtensson, Lars‐Göran ; Appell, Malin Lindqvist</creator><creatorcontrib>Zimdahl Kahlin, Anna ; Helander, Sara ; Wennerstrand, Patricia ; Vikingsson, Svante ; Mårtensson, Lars‐Göran ; Appell, Malin Lindqvist</creatorcontrib><description>The discovery and implementation of thiopurine methyltransferase (TPMT) pharmacogenetics has been a success story and has reduced the suffering from serious adverse reactions during thiopurine treatment of childhood leukaemia and inflammatory bowel disease. This MiniReview summarizes four studies included in Dr Zimdahl Kahlin's doctoral thesis as well as the current knowledge on this field of research. The genotype‐phenotype concordance of TPMT in a cohort of 12 663 individuals with clinically analysed TPMT status is described. Notwithstanding the high concordance, the benefits of combined genotyping and phenotyping for TPMT status determination are discussed. The results from the large cohort also demonstrate that the factors of gender and age affect TPMT enzyme activity. In addition, characterization of four previously undescribed TPMT alleles (TPMT*41, TPMT*42, TPMT*43 and TPMT*44) shows that a defective TPMT enzyme could be caused by several different mechanisms. Moreover, the folate analogue methotrexate (MTX), used in combination with thiopurines during maintenance therapy of childhood leukaemia, affects the metabolism of thiopurines and interacts with TPMT, not only by binding and inhibiting the enzyme activity but also by regulation of its gene expression.</description><identifier>ISSN: 1742-7835</identifier><identifier>ISSN: 1742-7843</identifier><identifier>EISSN: 1742-7843</identifier><identifier>DOI: 10.1111/bcpt.13483</identifier><identifier>PMID: 32865889</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Children ; Enzymatic activity ; Enzyme activity ; Enzymes ; Folic acid ; Gene expression ; Genotypes ; Genotyping ; Inflammatory bowel diseases ; Intestine ; Leukemia ; Medical treatment ; Metabolism ; Methotrexate ; Methyltransferase ; Minireview ; Minireviews ; Pharmacogenetics ; Pharmacology ; Phenotypes ; Phenotyping ; Thiopurine S-methyltransferase</subject><ispartof>Basic &amp; clinical pharmacology &amp; toxicology, 2021-01, Vol.128 (1), p.52-65</ispartof><rights>2020 The Authors. published by John Wiley &amp; Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)</rights><rights>2020 The Authors. Basic &amp; Clinical Pharmacology &amp; Toxicology published by John Wiley &amp; Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).</rights><rights>2020. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33</citedby><cites>FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33</cites><orcidid>0000-0002-7642-9263 ; 0000-0001-5977-3049 ; 0000-0002-2809-7591</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32865889$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-170185$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Zimdahl Kahlin, Anna</creatorcontrib><creatorcontrib>Helander, Sara</creatorcontrib><creatorcontrib>Wennerstrand, Patricia</creatorcontrib><creatorcontrib>Vikingsson, Svante</creatorcontrib><creatorcontrib>Mårtensson, Lars‐Göran</creatorcontrib><creatorcontrib>Appell, Malin Lindqvist</creatorcontrib><title>Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism</title><title>Basic &amp; clinical pharmacology &amp; toxicology</title><addtitle>Basic Clin Pharmacol Toxicol</addtitle><description>The discovery and implementation of thiopurine methyltransferase (TPMT) pharmacogenetics has been a success story and has reduced the suffering from serious adverse reactions during thiopurine treatment of childhood leukaemia and inflammatory bowel disease. This MiniReview summarizes four studies included in Dr Zimdahl Kahlin's doctoral thesis as well as the current knowledge on this field of research. The genotype‐phenotype concordance of TPMT in a cohort of 12 663 individuals with clinically analysed TPMT status is described. Notwithstanding the high concordance, the benefits of combined genotyping and phenotyping for TPMT status determination are discussed. The results from the large cohort also demonstrate that the factors of gender and age affect TPMT enzyme activity. In addition, characterization of four previously undescribed TPMT alleles (TPMT*41, TPMT*42, TPMT*43 and TPMT*44) shows that a defective TPMT enzyme could be caused by several different mechanisms. Moreover, the folate analogue methotrexate (MTX), used in combination with thiopurines during maintenance therapy of childhood leukaemia, affects the metabolism of thiopurines and interacts with TPMT, not only by binding and inhibiting the enzyme activity but also by regulation of its gene expression.</description><subject>Children</subject><subject>Enzymatic activity</subject><subject>Enzyme activity</subject><subject>Enzymes</subject><subject>Folic acid</subject><subject>Gene expression</subject><subject>Genotypes</subject><subject>Genotyping</subject><subject>Inflammatory bowel diseases</subject><subject>Intestine</subject><subject>Leukemia</subject><subject>Medical treatment</subject><subject>Metabolism</subject><subject>Methotrexate</subject><subject>Methyltransferase</subject><subject>Minireview</subject><subject>Minireviews</subject><subject>Pharmacogenetics</subject><subject>Pharmacology</subject><subject>Phenotypes</subject><subject>Phenotyping</subject><subject>Thiopurine S-methyltransferase</subject><issn>1742-7835</issn><issn>1742-7843</issn><issn>1742-7843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp9ks1u1DAQxyMEoqVw4QFQJC4IKcUf8ca5IJXlU6pED4WrZTvjjavEDrZD2RsPwIFn5Elw2GVFe2AuHsm_-Wk0-hfFY4xOca4XSk_pFNOa0zvFMW5qUjW8pncPPWVHxYMYrxAiTY3R_eKIEr5inLfHxY-LXoZRar8BB8nqMqa5sxBLb8rUWz_NwTooR0j9dkhBumggyAhl5n3aTvDr-8-p3_el9k770EmnoZSuK8EY0GlxLQKfAnyTCUrvbrml8oON48PinpFDhEf796T49PbN5fp9df7x3Yf12Xmla76iley0MoagWhNVM6U62jCQrdJcAVMNNyvgBBGGFGpxxwlhmVBGGaaAY0npSVHtvPEaplmJKdhRhq3w0orX9vOZ8GEjBjsL3CDMWeZf7vgMj9BpcPkSw42xmz_O9mLjv4qGE4xZkwXP9oLgv8wQkxht1DAM0oGfoyA15W2L2npBn95Cr_wcXD5HphqMGGcIZer5jtLBxxjAHJbBSCyhEEsoxJ9QZPjJv-sf0L8pyADeAdd2gO1_VOLV-uJyJ_0NymHJlA</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Zimdahl Kahlin, Anna</creator><creator>Helander, Sara</creator><creator>Wennerstrand, Patricia</creator><creator>Vikingsson, Svante</creator><creator>Mårtensson, Lars‐Göran</creator><creator>Appell, Malin Lindqvist</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope><scope>5PM</scope><scope>ABXSW</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DG8</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0002-7642-9263</orcidid><orcidid>https://orcid.org/0000-0001-5977-3049</orcidid><orcidid>https://orcid.org/0000-0002-2809-7591</orcidid></search><sort><creationdate>202101</creationdate><title>Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism</title><author>Zimdahl Kahlin, Anna ; Helander, Sara ; Wennerstrand, Patricia ; Vikingsson, Svante ; Mårtensson, Lars‐Göran ; Appell, Malin Lindqvist</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Children</topic><topic>Enzymatic activity</topic><topic>Enzyme activity</topic><topic>Enzymes</topic><topic>Folic acid</topic><topic>Gene expression</topic><topic>Genotypes</topic><topic>Genotyping</topic><topic>Inflammatory bowel diseases</topic><topic>Intestine</topic><topic>Leukemia</topic><topic>Medical treatment</topic><topic>Metabolism</topic><topic>Methotrexate</topic><topic>Methyltransferase</topic><topic>Minireview</topic><topic>Minireviews</topic><topic>Pharmacogenetics</topic><topic>Pharmacology</topic><topic>Phenotypes</topic><topic>Phenotyping</topic><topic>Thiopurine S-methyltransferase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zimdahl Kahlin, Anna</creatorcontrib><creatorcontrib>Helander, Sara</creatorcontrib><creatorcontrib>Wennerstrand, Patricia</creatorcontrib><creatorcontrib>Vikingsson, Svante</creatorcontrib><creatorcontrib>Mårtensson, Lars‐Göran</creatorcontrib><creatorcontrib>Appell, Malin Lindqvist</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Linköpings universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Linköpings universitet</collection><collection>SwePub Articles full text</collection><jtitle>Basic &amp; clinical pharmacology &amp; toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zimdahl Kahlin, Anna</au><au>Helander, Sara</au><au>Wennerstrand, Patricia</au><au>Vikingsson, Svante</au><au>Mårtensson, Lars‐Göran</au><au>Appell, Malin Lindqvist</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism</atitle><jtitle>Basic &amp; clinical pharmacology &amp; toxicology</jtitle><addtitle>Basic Clin Pharmacol Toxicol</addtitle><date>2021-01</date><risdate>2021</risdate><volume>128</volume><issue>1</issue><spage>52</spage><epage>65</epage><pages>52-65</pages><issn>1742-7835</issn><issn>1742-7843</issn><eissn>1742-7843</eissn><abstract>The discovery and implementation of thiopurine methyltransferase (TPMT) pharmacogenetics has been a success story and has reduced the suffering from serious adverse reactions during thiopurine treatment of childhood leukaemia and inflammatory bowel disease. This MiniReview summarizes four studies included in Dr Zimdahl Kahlin's doctoral thesis as well as the current knowledge on this field of research. The genotype‐phenotype concordance of TPMT in a cohort of 12 663 individuals with clinically analysed TPMT status is described. Notwithstanding the high concordance, the benefits of combined genotyping and phenotyping for TPMT status determination are discussed. The results from the large cohort also demonstrate that the factors of gender and age affect TPMT enzyme activity. In addition, characterization of four previously undescribed TPMT alleles (TPMT*41, TPMT*42, TPMT*43 and TPMT*44) shows that a defective TPMT enzyme could be caused by several different mechanisms. Moreover, the folate analogue methotrexate (MTX), used in combination with thiopurines during maintenance therapy of childhood leukaemia, affects the metabolism of thiopurines and interacts with TPMT, not only by binding and inhibiting the enzyme activity but also by regulation of its gene expression.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32865889</pmid><doi>10.1111/bcpt.13483</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-7642-9263</orcidid><orcidid>https://orcid.org/0000-0001-5977-3049</orcidid><orcidid>https://orcid.org/0000-0002-2809-7591</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1742-7835
ispartof Basic & clinical pharmacology & toxicology, 2021-01, Vol.128 (1), p.52-65
issn 1742-7835
1742-7843
1742-7843
language eng
recordid cdi_swepub_primary_oai_DiVA_org_liu_170185
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
subjects Children
Enzymatic activity
Enzyme activity
Enzymes
Folic acid
Gene expression
Genotypes
Genotyping
Inflammatory bowel diseases
Intestine
Leukemia
Medical treatment
Metabolism
Methotrexate
Methyltransferase
Minireview
Minireviews
Pharmacogenetics
Pharmacology
Phenotypes
Phenotyping
Thiopurine S-methyltransferase
title Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T10%3A28%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacogenetic%20studies%20of%20thiopurine%20methyltransferase%20genotype%E2%80%90phenotype%20concordance%20and%20effect%20of%20methotrexate%20on%20thiopurine%20metabolism&rft.jtitle=Basic%20&%20clinical%20pharmacology%20&%20toxicology&rft.au=Zimdahl%20Kahlin,%20Anna&rft.date=2021-01&rft.volume=128&rft.issue=1&rft.spage=52&rft.epage=65&rft.pages=52-65&rft.issn=1742-7835&rft.eissn=1742-7843&rft_id=info:doi/10.1111/bcpt.13483&rft_dat=%3Cproquest_swepu%3E2471058500%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2471058500&rft_id=info:pmid/32865889&rfr_iscdi=true